Down-regulation of endothelial cell growth inhibitors by enhanced MYCN oncogene expression in human neuroblastoma cells

European Journal of Biochemistry

Volumn 263, Issue 3, 1999, Pages 757-764

  Fotsis, Theodore ^a,c   Breit, Stephen ^a   Lutz, Werner ^b   Rössler, Jochen ^a   Hatzi, Elissavet ^d   Schwab, Manfred ^b   Schweigerer, Lothar ^a  

^a UNIVERSITY HOSPITAL HEIDELBERG   (Germany)

^b GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

^c UNIVERSITY OF IOANNINA   (Greece)

^d NONE

Author keywords

Inhibitors; MYCN; Neuroblastoma; Oncogene; Tumor angiogenesis

Indexed keywords

BASIC FIBROBLAST GROWTH FACTOR; GROWTH INHIBITOR; TRANSFORMING GROWTH FACTOR BETA1;

ANGIOGENESIS; ANIMAL CELL; ARTICLE; CELL GROWTH; DOWN REGULATION; ENDOTHELIUM CELL; GENE EXPRESSION; GROWTH INHIBITION; HUMAN; HUMAN CELL; MALIGNANT TRANSFORMATION; NEOVASCULARIZATION (PATHOLOGY); NEUROBLASTOMA CELL; NONHUMAN; ONCOGENE C MYC; PRIORITY JOURNAL; PROGNOSIS; TUMOR GROWTH;

CELL DIVISION; CELL TRANSFORMATION, NEOPLASTIC; CELLS, CULTURED; CHROMATOGRAPHY, AFFINITY; CULTURE MEDIA, CONDITIONED; ENDOTHELIUM, VASCULAR; FIBROBLAST GROWTH FACTOR 2; GENE EXPRESSION REGULATION, NEOPLASTIC; GENES, MYC; GROWTH INHIBITORS; HUMANS; NEOVASCULARIZATION, PATHOLOGIC; NEUROBLASTOMA; PROTO-ONCOGENE PROTEINS C-MYC; RECOMBINANT PROTEINS; TUMOR CELLS, CULTURED;

EID: 0033178888     PISSN: 00142956     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1432-1327.1999.00575.x     Document Type: Article

References (23)

1. 1. Klagsbrun, M. & Folkman, J. (1990) Angiogenesis. In Peptide Growth Factors and Their Receptors II (Sporn, M.B. & Roberts, A.B., eds), pp. 549-586. Springer Verlag, Berlin.
2. 2. Folkman, J. & Cotran, R.S. (1976) Relation of vascular proliferation to tumor growth. Int. Rev. Exp. Pathol. 16, 207-248.
3. 3. Hanahan, D. & Folkman, J. (1996) Patterns and emerging mechanisms of the angiogenic switch during tumorigenesis. Cell 86, 353-364.
4. 4. Folkman, J. (1995) Angiogenesis in cancer, vascular, rheumatoid and other disease. Nature Med. 1, 27-31.
5. 5. Liotta, L.A., Steeg, P.S. & Stetler-Stevenson, W.G. (1991) Cancer metastasis and angiogenesis: an imbalance of positive and negative regulation. Cell 64, 327-336.
6. 6. Vogelstein, B. & Kinzler, K.W. (1993) The multistep nature of cancer. Trends Genet. 9, 138-141.
7. 7. Bishop, J.M. (1987) The molecular genetics of cancer. Science 235, 305-311.
8. 8. Dameron, K.M., Volpert, O.V., Tainsky, MA. & Bouck, N. (1994) Control of angiogenesis in fibroblasts by p53 regulation of thrombospondin-1. Science 265, 1582-1584.
9. 9. Volpert, O.V., Stellmach, V. & Bouck, N. (1996) The modulation of thrompospondin and other naturally occuring inhibitors of angiogenesis during tumor progression. Breast Cancer Res. Treat. 36, 119-126.
10. 10. Van Meir, E.G., Polverini, P.J., Chazin, V.R., Su Huang, H.J., De Tribolet, N. & Cavenee, W.K. (1994) Release of an inhibitor of angiogenesis upon induction of wild type p53 expression in glioblastoma cells. Nat. Genet. 8, 171-176.
11. 11. Bouck, N., Stellmach, V. & Hsu, S.C. (1996) How tumors become angiogenic. Adv. Cancer Res. 69, 135-174.
12. 12. Brodeur, G.M., Seeger, R.C., Schwab, M., Varmus, H.E. & Bishop, J.M. (1984) Amplification of MYCN in untreated human neuroblastomas correlates with advanced disease stage. Science 224, 1121-1124.
13. 13. Grady-Leopardi, E., Schwab, M., Ablin, A. & Rosenau, W. (1986) Detection of NMYC oncogene expression in human neuroblastoma by in situ hybridization and blot analysis: Relationship to clinical outcome. Cancer Res. 46, 3196-3199.
14. 14. Meitar, D., Crawford, S.E., Radmaker, A.W. & Cohn, S.L. (1996) Tumor angiogenesis correlates with metastatic disease, N-myc amplification, and poor outcome in human neuroblastoma. J. Clin. Oncot. 14, 405-414.
15. 15. Schweigerer, L., Breit, S., Wenzel, A., Tsunamoto, K., Ludwig, R. & Schwab, M. (1990) Augmented MYCN expression advances the malignant phenotype of human neuroblastoma cells: Evidence for induction of autocrine growth activity. Cancer Res. 50, 4411-4416.
16. 16. Folsis, T., Pepper, M.S., Aktas, E., Breit, S., Rasku, S., Adlercreutz, H., Wähälä, K., Montesano, R. & Schweigerer, L. (1997) Flavonoids, dietary-derived inhibitors of cell proliferation and in vitro angiogenesis. Cancer Res. 57, 2916-2921.
17. 17. Fotsis, T., Zhang, Y., Pepper, M.S., Adlercreutz, H., Montesano, R., Nawroth, P.P. & Schweigerer, L. (1994) The endogenous estrogen metabolite 2-methoxyestradiol inhibits angiogenesis and suppresses tumor growth. Nature 368, 237-239.
18. 18. Schweigerer, L., Neufeld, G., Friedman, J., Abraham, J.A., Fiddes, J.C. & Gospodarowicz, D. (1987) Capillary endothelial cells express basic fibroblast growth factor, a mitogen that promotes their own growth. Nature 325, 257-259.
19. 19. Lutz, W., Stöhr, M., Schürmann, J., Wenzel, A., Löhr, A. & Schwab, M. (1996) Conditional expression of N-myc in human neuroblastoma cells increases expression of a-prothymosin and ornithine decarboxylase and accelerates progression into S-phase early after mitogenic stimulation of quiescent cells. Oncogene 13, 803-812.
20. 20. Wilm, M., Shevehenko, A., Houthaeve, T., Breit, S., Schweigerer, L., Fotsis, T. & Mann, M. (1996) Femtomole sequencing of proteins from polyacrylamide gels by nano-electrospray mass spectrometry. Nature 379, 466-469.
21. 21. Gossen, M. & Bujard, H. (1992) Tight control of gene expression in mammalian cells by tetracyclin-responsive promoters. Proc. Natl Acad. Sci. USA 89, 5547-5551.
22. 22. Gossen, M., Freundlieb, S., Bender, G.M., Müller, G., Hillen, W. & Bujard, H. (1995) Transcriptional activation by tetracyclines in mammalian cells. Science 268, 1766-1769.
23. 23. Denekamp, J. (1990) Vascular attack as a therapeutic strategy for cancer. Cancer Met. Rev. 9, 267-282.